News

Six new COST Innovators Grants approved

Six new COST Innovators Grants approved
Funding, Innovation & research
Member News, Funding news

On 29 June 2022, COST’s governing board, the Committee of Senior Officials (CSO) approved funding for six new COST Innovators Grants (CIGs).

What is a COST Innovators Grant?

The COST Innovators Grant, as defined in the COST Strategic Plan, aims to enhance the pace and success of breakthrough innovations, build bridges between the scientific research performed in COST Actions and marketable applications and/or societal solutions, and explore innovation potential.

Launched in 2019 as a pilot scheme, CIGs are now a fully established feature for COST under Horizon Europe. Eligible COST Actions that are reaching the end of their initial 4-year funding period are invited to apply for CIG funding by the COST Association. CIGs have a duration of 12 months and grantees benefit from the same networking activities available to COST Actions.

NEWS​

Related News

Gnomon Informatics Kicks Off 2025 with a Strong Presence at Arab Health & Athens Digital Health Week!

4 Feb 2025
January was a dynamic month for Gnomon Informatics, as we showcased our innovations in digital health at two major industry events—Arab Health and Ath...

Postmodern EHR: Evolution, not revolution

4 Feb 2025
Once hailed as revolutionary, the traditional monolithic Electronic Health Record (EHR) systems now show limitations. These mega suites were designed ...

Publication by DTH-Lab & Data Solidarity Project team University of Vienna: Data solidarity operationalising public value through a digital tool

4 Feb 2025
Data governance isn't just about rules—it's about people. In this article, DTH-Lab Director, Ilona Kickbusch with co-authors Barbara Prainsack and Sel...

Digital Health Compliance Trends: Top Standards for 2025

4 Feb 2025
A study of digital health innovators asked which standards they plan to meet in 2025. Benchmark your compliance plans, by reading our article to disco...

HLTH Community & Novartis Present Latest Industry Report: Unblocking Innovations in Drug Development

4 Feb 2025
The HLTH Community & Novartis report, Unblocking Innovations in Drug Development, dives into the critical challenges hindering AI and digital inno...

Evondos Group – attending events and exhibitions in both the UK and Spain this spring

4 Feb 2025
Are you curious to test out and see the latest welfare technology that is taking the Nordics by storm? Don't miss out on which events and exhibitions ...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *